Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $13.82 USD
Change Today +0.30 / 2.22%
Volume 179.6K
RXDX On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

ignyta inc (RXDX) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/11/15 - $19.40
52 Week Low
11/20/14 - $6.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IGNYTA INC (RXDX)

Related News

No related news articles were found.

ignyta inc (RXDX) Related Businessweek News

No Related Businessweek News Found

ignyta inc (RXDX) Details

Ignyta, Inc., a precision oncology biotechnology company, engages in discovering or acquiring, developing, and commercializing new drugs for cancer patients. Its products pipeline consists of entrectinib, a tyrosine kinase inhibitor directed to the Trk family tyrosine kinase receptors, ROS1, and ALK proteins, which is in two Phase I/II clinical studies in molecularly defined patient populations for the treatment of solid tumors; and RXDX-103, a development program targeting the cell division cycle 7-related and protein kinase. The company was founded in 2011 and is based in San Diego, California.

82 Employees
Last Reported Date: 08/10/15
Founded in 2011

ignyta inc (RXDX) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $608.3K
Chief Financial Officer
Total Annual Compensation: $260.4K
Chief Operating Officer
Total Annual Compensation: $455.1K
Compensation as of Fiscal Year 2014.

ignyta inc (RXDX) Key Developments

Ignyta, Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Ignyta, Inc. announced unaudited earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported loss from operations of USD 12,651,000 compared to USD 5,465,000 a year ago. Net loss was USD 13,120,000 or USD 0.51 per basic and diluted share compared to USD 5,423,000 or USD 0.28 per basic and diluted share a year ago. For the six months, the company reported loss from operations of USD 35,633,000 compared to USD 9,408,000 a year ago. Net loss was USD 36,626,000 or USD 1.58 per basic and diluted share compared to USD 9,529,000 or USD 0.56 per basic and diluted share a year ago.

Ignyta, Inc. to Report Q2, 2015 Results on Aug 10, 2015

Ignyta, Inc. announced that they will report Q2, 2015 results After-Market on Aug 10, 2015

Ignyta, Inc., Q2 2015 Earnings Call, Aug 10, 2015

Ignyta, Inc., Q2 2015 Earnings Call, Aug 10, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RXDX:US $13.82 USD +0.30

RXDX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RXDX.
View Industry Companies

Industry Analysis


Industry Average

Valuation RXDX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 2.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IGNYTA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at